Skip to content

RECCORD (Recording Courses of Vascular Diseases) Registry

RECCORD - Recording Courses of Vascular Diseases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03448029
Acronym
RECCORD
Enrollment
6000
Registered
2018-02-27
Start date
2018-01-01
Completion date
2024-12-31
Last updated
2021-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Claudication, Critical Limb Ischemia, Diabetic Foot, Peripheral Artery Disease, Vascular Diseases

Keywords

Vascular Diseases, Peripheral Artery Disease, Revascularisation, Outcome, Quality Management, Registry, Endovascular Intervention, Limb Amputation

Brief summary

The RECording COurses of vasculaR Diseases registry (RECCORD registry) is an observational, prospective, multicentre, all-comers registry platform. In the initial phase, patients referred for endovascular revascularization of peripheral artery disease (PAD) of the lower limbs will be prospectively included and followed up for at least one year. At baseline, data on patients' demographic characteristics, comorbidities, previous peripheral interventions, medication, and clinical stage of PAD (Rutherford category), haemodynamic parameters, and procedural data including complications will be assessed. Major adverse cardiac and limb events will be recorded at planned (at six and 12 months) and at any unplanned visits. For details see NM Malyar et al., Rationale and design of the RECording COurses of vasculaR Diseases registry (RECCORD registry). Vasa. https://doi.org/10.1024/0301-1526/a000631

Detailed description

For details see NM Malyar et al., Rationale and design of the RECording COurses of vasculaR Diseases registry (RECCORD registry). Vasa. https://doi.org/10.1024/0301-1526/a000631

Interventions

None listed

Sponsors

Deutsche Gesellschaft für Angiologie, Gesellschaft für Gefäßmedizin e.V.
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* any type of endovascular interventions for symptomatic PAD * endovascular intervention for PAD of lower extremities, i.e. below the aorto-iliac bifurcation

Exclusion criteria

* patients undergoing hybrid-(surgical and endovascular) and/or surgical interventions for symptomatic PAD * patients with a life expectancy of \<6 months * endovascular intervention for reasons other than symptomatic PAD

Design outcomes

Primary

MeasureTime frameDescription
Outcome Quality after Revascularization: ComplicationsUp to 1 monthPeri- and post-interventional complications (puncture-site complications & intervention-related complications over 30 days
Outcome Quality after Revascularization: AmputationUp to 12 monthsAmputation-free survival (AFS)
Outcome Quality after Revascularization: SurvivalUp to 12 monthsSurvival at one year in CLI patients
Quality of Life: EQ-5D-5L questionnaireAt baseline, at 6 and 12 monthsEQ-5D-5L questionnaire to asses patient's health state and patient's self-rated health
Outcome Quality after Revascularization: Re-InterventionUp to 12 monthsNumber of re-interventions

Countries

Germany

Contacts

Primary ContactUlrich Hoffmann, Prof.
info@reccord.de0049-30-20888831
Backup ContactNasser Malyar, Dr.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026